These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 2843573

  • 1. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K, Furukawa Y, Miura R, Yumita S, Sohn HE, Yoshinaga K.
    J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
    [Abstract] [Full Text] [Related]

  • 2. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K, Furukawa Y, Goto MM, Abe K.
    Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
    [Abstract] [Full Text] [Related]

  • 3. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K, Furukawa Y, Abe K, Yoshinaga K.
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW, Hollis BW, Bell NH, Epstein S.
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
    Unakami H.
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar 20; 58(3):234-47. PubMed ID: 6980145
    [Abstract] [Full Text] [Related]

  • 7. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K, Kracht U, Wohlfart K, Kruse U.
    Eur J Pediatr; 1989 Apr 20; 148(6):535-9. PubMed ID: 2744015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
    Kanatani M, Sugimoto T, Kaji H, Ikeda K, Chihara K.
    Eur J Endocrinol; 2001 Mar 20; 144(3):263-9. PubMed ID: 11248746
    [Abstract] [Full Text] [Related]

  • 10. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
    Furukawa Y, Sohn H, Unakami H, Yumita S.
    Contrib Nephrol; 1980 Mar 20; 22():68-73. PubMed ID: 7398339
    [Abstract] [Full Text] [Related]

  • 11. Hypoparathyroidism and pseudohypoparathyroidism.
    Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M.
    Arq Bras Endocrinol Metabol; 2006 Aug 20; 50(4):664-73. PubMed ID: 17117292
    [Abstract] [Full Text] [Related]

  • 12. Ratio of baseline level/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism.
    Mizunashi K, Furukawa Y, Goto MM.
    Calcif Tissue Int; 1998 Feb 20; 62(2):99-103. PubMed ID: 9437041
    [Abstract] [Full Text] [Related]

  • 13. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Miura R, Yumita S, Yoshinaga K, Furukawa Y.
    Calcif Tissue Int; 1990 May 20; 46(5):309-13. PubMed ID: 2159833
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
    Yamamoto M, Takuwa Y, Masuko S, Ogata E.
    J Clin Endocrinol Metab; 1988 Mar 20; 66(3):618-25. PubMed ID: 2832440
    [Abstract] [Full Text] [Related]

  • 16. [Studies on the measurement of vitamin D derivatives in human plasma. III. Plasma concentrations of vitamin D derivatives in various diseases (author's transl)].
    Dokoh S, Morita R, Fukunaga M, Yamamoto I, Shigeno C, Yamamoto A, Yamada K, Torizuka K.
    Nihon Naibunpi Gakkai Zasshi; 1982 May 20; 58(5):758-70. PubMed ID: 6286379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW, Fraser D, DeLuca HF, Holick MF, Belsey RE, Clark MB, Murray TM.
    N Engl J Med; 1975 Oct 23; 293(17):840-4. PubMed ID: 170516
    [Abstract] [Full Text] [Related]

  • 19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Oct 23; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 20. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
    Lawoyin S, Norman DA, Zerwekh JE, Breslau NA, Pak CY.
    J Clin Endocrinol Metab; 1979 Nov 23; 49(5):783-6. PubMed ID: 489718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.